{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:07Z","timestamp":1791910567946,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vph.2024.107397","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T23:45:54Z","timestamp":1718667954000},"page":"107397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia\/reperfusion injury"],"prefix":"10.1016","volume":"156","author":[{"given":"Simone","family":"Gastaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magal\u00ec","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Blua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rubeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saveria","family":"Femmin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Comit\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gianquinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Landolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Gallicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Spyrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bertinaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2024.107397_bb0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/cvr\/cvy304","article-title":"Innate immunity as a target for acute cardioprotection","volume":"115","author":"Zuurbier","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2024.107397_bb0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/ars.2010.3245","article-title":"Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling","volume":"14","author":"Pagliaro","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2024.107397_bb0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1242\/dmm.003855","article-title":"Cardiac preconditioning for ischaemia: lost in translation","volume":"3","author":"Ludman","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.vph.2024.107397_bb0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00395-013-0392-7","article-title":"Redox balance and cardioprotection","volume":"108","author":"Tullio","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/molecules26040976","article-title":"NLRP3 inflammasome inhibitors in cardiovascular diseases","volume":"26","author":"Mezzaroma","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.vph.2024.107397_bb0035","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","author":"Toldo","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0040","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ejcts\/ezz383","article-title":"Toll-like receptor 3 mediates ischaemia\/reperfusion injury after cardiac transplantation","volume":"57","author":"Gollmann-Tepek\u00f6yl\u00fc","year":"2020","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.vph.2024.107397_bb0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2024.107397_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5271251","article-title":"Pharmacological inhibition of NLRP3 Inflammasome attenuates myocardial ischemia\/reperfusion injury by activation of RISK and mitochondrial pathways","volume":"2016","author":"Mastrocola","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.vph.2024.107397_bb0055","doi-asserted-by":"crossref","first-page":"9219825","DOI":"10.1155\/2020\/9219825","article-title":"Ticagrelor conditioning effects are not additive to Cardioprotection induced by direct NLRP3 Inflammasome inhibition: role of RISK, NLRP3, and redox cascades","volume":"2020","author":"Penna","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.vph.2024.107397_bb0060","doi-asserted-by":"crossref","first-page":"3480637","DOI":"10.1155\/2016\/3480637","article-title":"Maladaptive modulations of NLRP3 Inflammasome and Cardioprotective pathways are involved in diet-induced exacerbation of myocardial ischemia\/reperfusion injury in mice","volume":"2016","author":"Mastrocola","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.vph.2024.107397_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.vph.2024.107397_bb0070","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/med.21781","article-title":"NLRP3 inflammasome in cardiovascular diseases: pathophysiological and pharmacological implications","volume":"41","author":"Pellegrini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.vph.2024.107397_bb0075","doi-asserted-by":"crossref","first-page":"H1553","DOI":"10.1152\/ajpheart.00158.2018","article-title":"Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury","volume":"315","author":"Toldo","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2024.107397_bb0080","unstructured":"Y-J. Bai, Z-G. Li, W.H. Liu, D. Gao, P.Y. Zhang, M. Liu. Effects of IL-1\u03b2 and IL-18 induced by NLRP3 inflammasome activation on myocardial reperfusion injury after PCI. Eur. Rev. Med. Pharmacol. Sci. 23 (2019) 10101\u201310106. doi: 10.26355\/eurrev_201911_19579."},{"key":"10.1016\/j.vph.2024.107397_bb0085","doi-asserted-by":"crossref","first-page":"4293206","DOI":"10.1155\/2020\/4293206","article-title":"NLRP3 Inflammasome and its central role in the cardiovascular diseases","volume":"2020","author":"Tong","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.vph.2024.107397_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/FJC.0000000000000696","article-title":"NLRP3 Inflammasome in Cardioprotective signaling","volume":"74","author":"Zuurbier","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2024.107397_bb0095","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/antiox12071396","article-title":"Inhibitors of NLRP3 Inflammasome in ischemic heart disease: focus on functional and redox aspects","volume":"12","author":"Pagliaro","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.vph.2024.107397_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000658","article-title":"The NLRP3 Inflammasome inhibitor, OLT1177 (Dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse","volume":"73","author":"Toldo","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2024.107397_bb0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/FJC.0000000000000053","article-title":"A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse","volume":"63","author":"Marchetti","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2024.107397_bb0115","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.3390\/ijms22084208","article-title":"Cyclic Nigerosyl-Nigerose as oxygen Nanocarrier to protect cellular models from hypoxia\/Reoxygenation injury: implications from an in vitro model","volume":"22","author":"Penna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2024.107397_bb0120","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1093\/ilar.53.1.55","article-title":"Mice anesthesia, analgesia, and care, part I: anesthetic considerations in preclinical research","volume":"53","author":"Gargiulo","year":"2012","journal-title":"ILAR J."},{"key":"10.1016\/j.vph.2024.107397_bb0125","first-page":"146","article-title":"A TRICk to improve the effectiveness of RIC: role of limb temperature in enhancing the effectiveness of remote ischemic conditioning","volume":"11","author":"Penna","year":"2022","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.vph.2024.107397_bb0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00395-014-0418-9","article-title":"Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia\/reperfusion injury","volume":"109","author":"Penna","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0135","doi-asserted-by":"crossref","first-page":"H719","DOI":"10.1152\/ajpheart.00394.2008","article-title":"PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-kinase\/Akt and NO pathway","volume":"296","author":"Bulhak","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2024.107397_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection","volume":"113","author":"B\u00f8tker","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0145","article-title":"Extracellular vesicles from patients with acute coronary syndrome impact on ischemia-reperfusion injury","volume":"170","author":"D'Ascenzo","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.vph.2024.107397_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120653","article-title":"Epimedin a ameliorates DNFB-induced allergic contact dermatitis in mice: role of NF-\u03baB\/NLRP3-driven pyroptosis, Nrf2\/HO-1 pathway, and inflammation modulation","volume":"302","author":"Balaha","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2024.107397_bb0155","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1021\/jm501072b","article-title":"Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis","volume":"57","author":"Cocco","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vph.2024.107397_bb0160","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1021\/acs.jmedchem.6b01624","article-title":"Development of an acrylate derivative targeting the NLRP3 Inflammasome for the treatment of inflammatory bowel disease","volume":"60","author":"Cocco","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vph.2024.107397_bb0165","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3389\/fphar.2018.01405","article-title":"A comparative study on the efficacy of NLRP3 Inflammasome signaling inhibitors in a pre-clinical model of bowel inflammation","volume":"9","author":"Pellegrini","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2024.107397_bb0170","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.3390\/molecules26133975","article-title":"Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor","volume":"26","author":"Gastaldi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.vph.2024.107397_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115542","article-title":"Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation","volume":"257","author":"Gastaldi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.vph.2024.107397_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of Inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.vph.2024.107397_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127560","article-title":"Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors","volume":"30","author":"Harrison","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.vph.2024.107397_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00395-014-0415-z","article-title":"TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia\/reperfusion injury","volume":"109","author":"Liu","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0195","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.3390\/molecules26123534","article-title":"Preservation of contractile reserve and diastolic function by inhibiting the NLRP3 Inflammasome with OLT1177\u00ae (Dapansutrile) in a mouse model of severe ischemic cardiomyopathy due to non-Reperfused Anterior Wall myocardial infarction","volume":"26","author":"Aliaga","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.vph.2024.107397_bb0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0205","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.yjmcc.2011.02.018","article-title":"Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion","volume":"50","author":"Bell","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.RES.0000260203.55077.61","article-title":"A role for caspase-1 in heart failure","volume":"100","author":"Merkle","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2024.107397_bb0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2024.107397_bb0220","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/MCB.17.9.5328","article-title":"Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis","volume":"17","author":"Chin","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.vph.2024.107397_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00395-021-00898-0","article-title":"Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function","volume":"116","author":"Comit\u00e0","year":"2021","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2024.107397_bb0230","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2024.107397_bb0235","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2018.00114","article-title":"Oxidative stress and NLRP3-Inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications","volume":"9","author":"Sharma","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2024.107397_bb0240","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1021\/acs.jmedchem.3c01370","article-title":"Recent Progress and prospects of small molecules for NLRP3 Inflammasome inhibition","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912400123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912400123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T20:45:34Z","timestamp":1738183534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718912400123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":48,"alternative-id":["S153718912400123X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107397","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia\/reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107397"}}